Furthermore, Gordian et al. [70] showed that the TGF-β-EMT signature may be considered as a potential predictive biomarker, as they successfully discriminated lung cancer cell lines undergoing TGF-β-induced EMT and predicted metastasis-free survival in lung adenocarcinomas [70]. This evidence concerns the gene TGFB1 and lung adenocarcinoma.